{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetic retinopathy", "high-mobility group box-1", "nuclear factor-kappa B", "receptor for advanced glycation end products"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26950148", "DateCompleted": {"Year": "2016", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "03", "Day": "03"}], "ELocationID": ["140", "10.3390/nu8030140"], "Language": ["eng"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "8", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Mar", "Day": "03"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.", "Pagination": {"StartPage": "140", "MedlinePgn": "140"}, "Abstract": {"AbstractText": ["High-mobility group box-1 (HMGB1) is a well-known pro-inflammatory cytokine. We aimed to investigate the effect of the ethanol extract of the root of P. cuspidatum (PCE) on retinal inflammation in diabetic retinopathy. PCE (100 or 350 mg/kg/day) was administered to diabetic rats for 16 weeks, and hyperglycemia and body weight loss developed in the diabetic rats. The retinal expression levels of HMGB1 and receptor for advanced glycation end products (RAGE) and the activity of nuclear factor-kappa B (NF-\u03baB) in the retina were examined. Additionally, a chromatin immunoprecipitation assay was performed to analyze the binding of NF-\u03baB binding to the RAGE promoter in the diabetic retinas. The levels of HMGB1 and RAGE expression, NF-\u03baB activity, and NF-\u03baB binding to the RAGE promoter were increased in the diabetic retinas. However, treatment with PCE ameliorated the increases in HMGB1 and RAGE expression, and NF-\u03baB activity in the retina. In addition, in diabetic rats, retinal vascular permeability and the loosening of the tight junctions were inhibited by PCE. These findings suggest that PCE has a preventative effect against diabetes-induced vascular permeability by inhibiting HMGB1-RAGE-NF-\u03baB activation in diabetic retinas. The oral administration of PCE may significantly help to suppress the development of diabetic retinopathy in patients with diabetes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. ssen4022@kiom.re.kr."}], "LastName": "Sohn", "ForeName": "Eunjin", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. dvmhyun@kiom.re.kr."}], "LastName": "Kim", "ForeName": "Junghyun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. chskim@kiom.re.kr."}], "LastName": "Kim", "ForeName": "Chan-Sik", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. candykong@kiom.re.kr."}], "LastName": "Lee", "ForeName": "Yun Mi", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. jskim@kiom.re.kr."}], "LastName": "Kim", "ForeName": "Jin Sook", "Initials": "JS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ager protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "HMGB1 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Hbp1 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptor for Advanced Glycation End Products"}, {"RegistryNumber": "5W494URQ81", "NameOfSubstance": "Streptozocin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Capillary Permeability"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["chemically induced", "metabolism", "prevention & control"], "DescriptorName": "Diabetic Retinopathy"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fallopia japonica"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "HMGB1 Protein"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptor for Advanced Glycation End Products"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Retina"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Retinal Vessels"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Streptozocin"}, {"QualifierName": [], "DescriptorName": "Weight Gain"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adamis A.P. Is diabetic retinopathy an inflammatory disease? Br. J. Ophthalmol. 2002;86:363\u2013365. doi: 10.1136/bjo.86.4.363.", "ArticleIdList": ["10.1136/bjo.86.4.363", "PMC1771111", "11914197"]}, {"Citation": "Santos A.R., Dvoriantchikova G., Li Y., Mohammad G., Abu El-Asrar A.M., Wen R., Ivanov D. Cellular mechanisms of high mobility group 1 (HMGB-1) protein action in the diabetic retinopathy. PLoS ONE. 2014;9:140. doi: 10.1371/journal.pone.0087574.", "ArticleIdList": ["10.1371/journal.pone.0087574", "PMC3909191", "24498140"]}, {"Citation": "Voll R.E., Urbonaviciute V., Herrmann M., Kalden J.R. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr. Med. Assoc. J. 2008;10:26\u201328.", "ArticleIdList": ["18300566"]}, {"Citation": "Lee Y.M., Kim J., Jo K., Shin S.D., Kim C.S., Sohn E.J., Kim S.G., Kim J.S. Ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating HMGB1 expression. J. Diabetes Res. 2013;2013 doi: 10.1155/2013/245271.", "ArticleIdList": ["10.1155/2013/245271", "PMC3858882", "24371837"]}, {"Citation": "Mohammad G., Siddiquei M.M., Othman A., Al-Shabrawey M., Abu El-Asrar A.M. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp. Eye Res. 2013;107:101\u2013109. doi: 10.1016/j.exer.2012.12.009.", "ArticleIdList": ["10.1016/j.exer.2012.12.009", "23261684"]}, {"Citation": "Luan Z.G., Zhang H., Yang P.T., Ma X.C., Zhang C., Guo R.X. HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology. 2010;215:956\u2013962. doi: 10.1016/j.imbio.2009.11.001.", "ArticleIdList": ["10.1016/j.imbio.2009.11.001", "20163887"]}, {"Citation": "El-Asrar A.M., Nawaz M.I., Kangave D., Geboes K., Ola M.S. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol. Vis. 2011;17:1829\u20131838.", "ArticleIdList": ["PMC3137555", "21850157"]}, {"Citation": "Kim J., Sohn E., Kim C.S., Jo K., Kim J.S. The role of high-mobility group box-1 protein in the development of diabetic nephropathy. Am. J. Nephrol. 2011;33:524\u2013529. doi: 10.1159/000327992.", "ArticleIdList": ["10.1159/000327992", "21606643"]}, {"Citation": "Lim B.O., Lee J.H., Ko N.Y., Mun S.H., Kim J.W., Kim do K., Kim J.D., Kim B.K., Kim H.S., Her E., et al. Polygoni cuspidati radix inhibits the activation of Syk kinase in mast cells for antiallergic activity. Exp. Biol. Med. 2007;232:1425\u20131431. doi: 10.3181/0705-RM-118.", "ArticleIdList": ["10.3181/0705-RM-118", "18040066"]}, {"Citation": "Peng W., Qin R., Li X., Zhou H. Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: A review. J. Ethnopharmacol. 2013;148:729\u2013745. doi: 10.1016/j.jep.2013.05.007.", "ArticleIdList": ["10.1016/j.jep.2013.05.007", "23707210"]}, {"Citation": "Kirino A., Takasuka Y., Nidhi A., Kawabe S., Yamashita H., Kimoto M., Ito H., Tsuji H. Analysis and functionality of major polypenolic components of Polugonum cuspidatum (Itadory) J. Nutr. Sci. Vitaminol. 2012;58:278\u2013286. doi: 10.3177/jnsv.58.278.", "ArticleIdList": ["10.3177/jnsv.58.278", "23132312"]}, {"Citation": "Bob F., Philippe S. The treatment of modern medical diseases with Chinese Medicine. In: Flaws B., Sionneau P., editors. Text Book and Clinal Manual. Blue Poppy; Colorado, CO, USA: 1897."}, {"Citation": "Han J.H., Koh W., Lee H.J., Lee E.O., Lee S.J., Khilc J.H., Tae K.J., Jeonga S.J., Kim S.H. Analgesic and anti-inflammatory effects of ethyl acetate fraction of Polygonum cuspidatum in experimental animals. Immunopharmacol. Immunotoxicol. 2012;34:191\u2013195. doi: 10.3109/08923973.2011.590499.", "ArticleIdList": ["10.3109/08923973.2011.590499", "21711083"]}, {"Citation": "Zhang H., Yu C.H., Jiang Y.P., Peng C., He K., Tang J.Y., Xin H.L. Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice. PLoS ONE. 2012;7:140. doi: 10.1371/journal.pone.0046574.", "ArticleIdList": ["10.1371/journal.pone.0046574", "PMC3461010", "23029551"]}, {"Citation": "Fei H.H., Xiao Z.D., Gao W. Effects of giant knotweed rhizome medicine on the expressions of RAGE and VEGF of rats with diabetic nephropathy. J. Shandong Univ. Health Sci. 2008;46:43\u201347."}, {"Citation": "Zhang W., Liu H., Rojas M., Caldwell R.W., Caldwell R.B. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy. 2011;3:609\u2013628. doi: 10.2217/imt.11.24.", "ArticleIdList": ["10.2217/imt.11.24", "PMC3671852", "21554091"]}, {"Citation": "Zhang W., Xu Q., Wu J., Zhou X., Weng J., Xu J., Wang W., Huang Q., Guo X. Role of Src in vascular hyperpermeability induced by advanced glycation end products. Sci. Rep. 2015;18 doi: 10.1038/srep14090.", "ArticleIdList": ["10.1038/srep14090", "PMC4585381", "26381822"]}, {"Citation": "Tan Z., Xu Z., Gui Q., Wu W., Yang Y. Gliquidone versus metformin: Differential effects on aorta in streptozotocin induced diabetic rats. Chin. Med. J. 2014;127:1298\u20131303.", "ArticleIdList": ["24709184"]}, {"Citation": "Liu W.J., Xie S.H., Liu Y.N., Kim W., Jin H.Y., Park S.K., Shao Y.M., Park T.S. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 2012;340:248\u2013255. doi: 10.1124/jpet.111.186866.", "ArticleIdList": ["10.1124/jpet.111.186866", "22025647"]}, {"Citation": "Gon\u00e7alves A., Marques C., Leal E., Ribeiro C.F., Reis F., Ambr\u00f3sio A.F., Fernandes R. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats. Biochim. Biophys. Acta. 2014;1842:1454\u20131463. doi: 10.1016/j.bbadis.2014.04.013.", "ArticleIdList": ["10.1016/j.bbadis.2014.04.013", "24769045"]}, {"Citation": "Davidson E.P., Coppey L.J., Dake B., Yorek M.A. Treatment of streptozotocin-induced diabetic rats with alogliptin: Effect on vascular and neural complications. Exp. Diabetes Res. 2011;2011 doi: 10.1155/2011/810469.", "ArticleIdList": ["10.1155/2011/810469", "PMC3142682", "21822422"]}, {"Citation": "Karuppagounder V., Arumugam S., Thandavarayan R.A., Pitchaimani V., Sreedhar R., Afrin R., Harima M., Suzuki H., Nomoto M., Miyashita S., et al. Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice. Int. Immunopharmacol. 2014;23:617\u2013623. doi: 10.1016/j.intimp.2014.10.014.", "ArticleIdList": ["10.1016/j.intimp.2014.10.014", "25466270"]}, {"Citation": "Manigrasso M.B., Juranek J., Ramasamy R., Schmidt A.M. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol. Metab. 2014;25:15\u201322. doi: 10.1016/j.tem.2013.08.002.", "ArticleIdList": ["10.1016/j.tem.2013.08.002", "PMC3877224", "24011512"]}, {"Citation": "McVicar C.M., Ward M., Colhoun L.M., Guduric-Fuchs J., Bierhaus A., Fleming T., Schlotterer A., Kolibabka M., Hammes H.P., Chen M., et al. Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. Diabetologia. 2015;58:1129\u20131137. doi: 10.1007/s00125-015-3523-x.", "ArticleIdList": ["10.1007/s00125-015-3523-x", "PMC4392170", "25687235"]}, {"Citation": "Chen M., Curtis T.M., Stitt A.W. Advanced glycation end products and diabetic retinopathy. Curr. Med. Chem. 2013;20:3234\u20133240. doi: 10.2174/09298673113209990025.", "ArticleIdList": ["10.2174/09298673113209990025", "23745547"]}, {"Citation": "Zong H., Ward M., Stitt A.W. AGEs, RAGE, and diabetic retinopathy. Curr. Diabetes Rep. 2011;11:244\u2013252. doi: 10.1007/s11892-011-0198-7.", "ArticleIdList": ["10.1007/s11892-011-0198-7", "21590515"]}, {"Citation": "Navaratna D., McGuire P.G., Menicucci G., Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes. 2007;56:2380\u20132387. doi: 10.2337/db06-1694.", "ArticleIdList": ["10.2337/db06-1694", "17536065"]}, {"Citation": "Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003;161:653\u2013660. doi: 10.1083/jcb.200302070.", "ArticleIdList": ["10.1083/jcb.200302070", "PMC2172943", "12743111"]}, {"Citation": "Leal E.C., Martins J., Voabil P., Liberal J., Chiavaroli C., Bauer J., Cunha-Vaz J., Ambr\u00f3sio A.F. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes. 2010;59:2637\u20132645. doi: 10.2337/db09-1421.", "ArticleIdList": ["10.2337/db09-1421", "PMC3279541", "20627932"]}, {"Citation": "Bralley E.E., Greenspan P., Hargrove J.L., Wicker L., Hartle D.K. Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J. Inflamm. 2008;5 doi: 10.1186/1476-9255-5-1.", "ArticleIdList": ["10.1186/1476-9255-5-1", "PMC2267461", "18261214"]}, {"Citation": "Kim Y.S., Lee Y.M., Kim J.H., Kim J.S. Polygonum cuspidatum inhibits pancreatic lipase activity and adipogenesis via attenuation of lipid accumulation. BMC Complement. Altern. Med. 2013;13:282. doi: 10.1186/1472-6882-13-282.", "ArticleIdList": ["10.1186/1472-6882-13-282", "PMC3819703", "24160551"]}, {"Citation": "Lee G., Choi T.W., Kim C., Nam D., Lee S.G., Jang H.J., Lee J.H., Um J.Y., Jung S.H., Shim B.S., et al. Anti-inflammatory activities of Reynoutria elliptica through suppression of mitogen-activated protein kinases and nuclear factor-kappaB activation pathways. Immunopharmacol. Immunotoxicol. 2013;34:454\u2013464. doi: 10.3109/08923973.2011.619195.", "ArticleIdList": ["10.3109/08923973.2011.619195", "21961440"]}, {"Citation": "Xu F., Wang Y., Cui W., Yuan H., Sun J., Wu M., Guo Q., Kong L., Wu H., Miao L. Resveratrol prevention of diabetic nephropathy is associated with the suppression of renal inflammation and mesangial cell proliferation: Possible roles of Akt/NF-kappab pathway. Int. J. Endocrinol. 2014;2014 doi: 10.1155/2014/289327.", "ArticleIdList": ["10.1155/2014/289327", "PMC3941586", "24672545"]}, {"Citation": "Zheng X., Zhu S., Chang S., Cao Y., Dong J., Li J., Long R., Zhou Y. Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: Role of NF-kappa B signaling. Eur. J. Pharmacol. 2013;720:147\u2013157. doi: 10.1016/j.ejphar.2013.10.034.", "ArticleIdList": ["10.1016/j.ejphar.2013.10.034", "24436987"]}, {"Citation": "Chen L., Lan Z., Lin Q., Mi X., He Y., Wei L., Lin Y., Zhang Y., Deng X. Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice. Food Chem. Toxicol. 2013;52:28\u201335. doi: 10.1016/j.fct.2012.10.037.", "ArticleIdList": ["10.1016/j.fct.2012.10.037", "23137955"]}, {"Citation": "Xie X., Peng J., Huang K., Huang J., Shen X., Liu P., Huang H. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-kappaB signaling pathway in rat glomerular mesangial cells. Mol. Cell. Endocrinol. 2012;362:183\u2013193. doi: 10.1016/j.mce.2012.06.008.", "ArticleIdList": ["10.1016/j.mce.2012.06.008", "22732364"]}, {"Citation": "Shrimali D., Shanmugam M.K., Kumar A.P., Zhang J., Tan B.K., Ahn K.S., Sethi G. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett. 2013;341:139\u2013149. doi: 10.1016/j.canlet.2013.08.023.", "ArticleIdList": ["10.1016/j.canlet.2013.08.023", "23962559"]}, {"Citation": "Lee W., Ku S.K., Kim T.H., Bae J.S. Emodin-6-O-beta-d-glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo. Food Chem. Toxicol. 2013;52:97\u2013104. doi: 10.1016/j.fct.2012.10.061.", "ArticleIdList": ["10.1016/j.fct.2012.10.061", "23146691"]}, {"Citation": "Kumar A., Dhawan S., Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene. 1998;17:913\u2013918. doi: 10.1038/sj.onc.1201998.", "ArticleIdList": ["10.1038/sj.onc.1201998", "9780008"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "11", "Day": "6"}, {"Year": "2016", "Month": "2", "Day": "18"}, {"Year": "2016", "Month": "2", "Day": "25"}, {"Year": "2016", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["26950148", "PMC4808869", "10.3390/nu8030140", "nu8030140"]}}], "PubmedBookArticle": []}